The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gender as a factor associated with poor compliance in the treatment of metastatic renal cell carcinoma with VEGF-targeted therapy in Japanese patients.
Motohide Uemura
No relevant relationships to disclose
Akira Tsujimura
No relevant relationships to disclose
Atsunari Kawashima
No relevant relationships to disclose
Yasuyuki Arai
No relevant relationships to disclose
Go Tanigawa
No relevant relationships to disclose
Mikio Nin
No relevant relationships to disclose
Yutaka Yasunaga
No relevant relationships to disclose
Toshiaki Yoshioka
No relevant relationships to disclose
Hironori Nomura
No relevant relationships to disclose
Masatoshi Mukai
No relevant relationships to disclose
Satoko Fukuda
No relevant relationships to disclose
Daizo Oka
No relevant relationships to disclose
Kenji Nishimura
No relevant relationships to disclose
Takahiro Yoshida
No relevant relationships to disclose
Mototaka Satou
No relevant relationships to disclose
Koji Hatano
No relevant relationships to disclose
Yasutomo Nakai
No relevant relationships to disclose
Hitoshi Takayama
No relevant relationships to disclose
Kazuo Nishimura
No relevant relationships to disclose
Norio Nonomura
No relevant relationships to disclose